These data suggest that the increase in the proportion of the activated TEff/Mem CD32a+ LILRA2+ CD57+ NKG2C+ subset occurred early during HIV infection and that it remained elevated, but to a lesser extent, after effective cART. Here, LILRA2 is linked to HIV infectious disease.